Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

2021106 citationsJournal Articlehybrid Open Access

Authors

Grzegorz S. Nowakowski · Mayo Clinic in Arizona

Fangxin Hong · Dana-Farber Cancer Institute

David W. Scott · Spinal Cord Injury BC

William R. Macon · Mayo Clinic in Arizona

Rebecca L. King · Mayo Clinic in Arizona

Thomas M. Habermann · Mayo Clinic in Arizona

Nina D. Wagner‐Johnston

Abstract

In this signal-seeking study, the addition of lenalidomide to R-CHOP (R2CHOP) improved outcomes in newly diagnosed DLBCL including patients with ABC-DLBCL.

Topics & Keywords

Lymphoma Diagnosis and Treatment CAR-T cell therapy research CNS Lymphoma Diagnosis and Treatment

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: Journal of Clinical Oncology

Volume 39, Issue 12, pp. 1329-1338

DOI: 10.1200/jco.20.01375

Field-Weighted Citation Impact: 13.28